To ramp up production of COVID-19 shots, the U.S. government is supporting a proposal to easing patent rules on these vaccines. Jackson Proskow explains what this means for developing nations and for Canada.
- U.S. backs waiver on vaccine patents. What it means and what Canada thinks
- U.S. IP waiver support rocks COVID-19 vaccine makers
- World mulls next step after U.S. supports waiving COVID-19 vaccine patents